Thursday, July 27, 2017

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer's disease

For decades researches have been investigating the underlying foundations of Alzheimer’s disease to provide clues for the design of a successful therapy. This week, VIB/KU Leuven scientists have published breakthrough insights in the prestigious journal Cell. A collaboration between Prof. Lucía Chávez-Gutiérrez and Prof. Bart De Strooper (both VIB-KU Leuven) revealed the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life. These new findings provide powerful insights for the design of novel therapeutic strategies to tackle the disease.The hereditary form of Alzheimer’s disease is caused by mutations in the Gamma Secretase enzyme and the APP protein. Gamma Secretase cuts APP several times in a progressive manner, with each cleavage generating a shorter fragment, called amyloid beta, which gets released into the brain.

from Dementia Big http://ift.tt/2eQXsWf via alcoholic dementia


http://ift.tt/2v2psMT

No comments:

Post a Comment